Opioid modulators for alcohol dependence
Authors:
- Thomas HillemacherTHThomas Hillemacher
- Annemarie HeberleinAHAnnemarie Heberlein
- Marc An MuschlerMMMarc An Muschler
- Stefan BleichSBStefan Bleich
- Helge FrielingHFHelge Frieling
- 9 June 2011
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 20 (8) , 1073-1086
Abstract
(2011). Opioid modulators for alcohol dependence. Expert Opinion on Investigational Drugs: Vol. 20, No. 8, pp. 1073-1086. doi: 10.1517/13543784.2011.592139Keywords
This publication has 137 references indexed in Scilit:
- Opioids in the hypothalamus control dopamine and acetylcholine levels in the nucleus accumbensBrain Research, 2010
- Naltrexone for the treatment of alcohol dependence among African Americans: Results from the COMBINE StudyDrug and Alcohol Dependence, 2009
- Synthesis and pharmacological evaluation of 6-naltrexamine analogs for alcohol cessationBioorganic & Medicinal Chemistry, 2009
- Human pituitary contains dual cathepsin L and prohormone convertase processing pathway components involved in converting POMC into the peptide hormones ACTH, α-MSH, and β-endorphinEndocrine, 2009
- Syntheses of novel high affinity ligands for opioid receptorsBioorganic & Medicinal Chemistry Letters, 2009
- A double-blind, placebo-controlled study of sertraline with naltrexone for alcohol dependenceDrug and Alcohol Dependence, 2009
- The Opioid Peptides Enkephalin and β-Endorphin in Alcohol DependenceBiological Psychiatry, 2008
- An Evaluation of μ-Opioid Receptor (OPRM1) as a Predictor of Naltrexone Response in the Treatment of Alcohol DependenceArchives of General Psychiatry, 2008
- Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findingsBiochemical Pharmacology, 2008
- New Insights into the Efficacy of Naltrexone Based on Trajectory-Based Reanalyses of Two Negative Clinical TrialsBiological Psychiatry, 2007